Summary
Pfizer Inc. filed its Form 10-Q for the quarterly period ending July 1, 1995, on August 14, 1995. This filing provides a snapshot of the company's financial performance and operational status during this period. While specific financial details such as revenue, net income, and balance sheet figures are not directly present in the provided snippet, the filing serves as an official update for investors regarding Pfizer's financial standing and ongoing business activities. Investors should review the full document for comprehensive information on the company's financial health, strategic initiatives, and any material events that may have occurred during the quarter.
Key Highlights
- 1Pfizer Inc. (PFE) filed a Form 10-Q for the quarterly period ending July 1, 1995.
- 2The filing was submitted to the SEC on August 14, 1995.
- 3This report provides investors with an update on Pfizer's financial performance and operational status for the second quarter of 1995.
- 4The 10-Q filing is a standard requirement for publicly traded companies to disclose financial information and other material developments.
- 5Investors can access this filing through the SEC's EDGAR database for detailed financial statements and management discussion.
- 6The provided content is a directory listing from the SEC's EDGAR system, indicating the availability of the full 10-Q document.